Key result
In older adults with acute myocardial injury, MINOCA was associated with a higher risk of all-cause mortality compared with revascularized ACS.
Why the study?
The prognostic significance of MINOCA in older adults remained uncertain, particularly compared with revascularized ACS and other acute myocardial injury phenotypes.
Does MINOCA carry a different all-cause mortality risk compared to revascularized ACS and other acute myocardial injury phenotypes in older adults?
Cohort (n=925)
No
Does MINOCA carry a different all-cause mortality risk compared to revascularized ACS and other acute myocardial injury phenotypes in older adults?
Answers are grounded in this paper and cite their sources.
In older adults, MINOCA is not a benign condition and is independently associated with higher long-term all-cause mortality compared to both revascularized ACS and other non-revascularized myocardial injury phenotypes.
Background: The prognostic significance of myocardial infarction with non-obstructive coronary arteries (MINOCA) in older adults remains uncertain, particularly in comparison with revascularized acute coronary syndromes (ACS) and other acute myocardial injury phenotypes. Methods: In the prospective population-based cohort of the Malmö Diet and Cancer Study (n = 30,466), 925 participants who experienced an incident coronary event between 2009 and 2018 were classified as revascularized ACS, MINOCA, or other acute myocardial injury phenotypes. All-cause mortality was assessed using Kaplan–Meier estimates and Cox proportional-hazards models. Results: Of 925 patients (mean age, 81 ± 7 years; female sex, 57%), 136 (14.7%) had a non-revascularized event, including 49 (36%) classified as MINOCA and 87 (64%) as other acute myocardial injuries. All non-revascularized cases underwent detailed review of angiographic and clinical records. During a median follow-up of 2.5 years, mortality was substantial across all groups (81%, overall). In unadjusted analyses, survival did not differ significantly among event categories (p = 0.302). In multivariable analysis, MINOCA was associated with increased mortality compared with revascularized ACS (aHR 1.48; 95% CI 1.07–2.05; p = 0.018) and with other acute myocardial injury phenotypes (aHR 1.44; 95% CI 1.01–2.04; p = 0.041). Other acute myocardial injury phenotypes did not differ significantly from revascularized ACS (aHR 1.03; 95% CI 0.78–1.35). Conclusions: MINOCA is associated with higher mortality than both revascularized ACS and other acute myocardial injury phenotypes. Despite the absence of obstructive coronary disease, MINOCA in later life carries an adverse prognosis and commands systematic diagnostic evaluation, careful phenotypic characterization, and appropriate risk-directed management.
No takes yet. Share an insight, caveat, or question.
Banihashemi et al. (2026) conducted a cohort in Acute myocardial injury (n=925). Myocardial infarction with non-obstructive coronary arteries (MINOCA) vs. Revascularized acute coronary syndromes (ACS) was evaluated on All-cause mortality (aHR 1.48, 95% CI 1.07-2.05, p=0.018). In older adults with acute myocardial injury, MINOCA was associated with a higher risk of all-cause mortality compared with revascularized ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: